A federal judge has rejected an insurance provider’s attempts to invalidate a $125 million settlement that the company, and several others, entered into with the makers of the sleep-disorder drug Provigil.

U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania on April 20 denied claims by United Healthcare Services that a 2015 memorandum of understanding aimed at settling antitrust claims against Cephalon and Teva over the anti-narcolepsy drug was merely part of the negotiating process and not a final agreement.